NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.”

Law 265

Law Patients Access Oil 265

NORML

MAY 26, 2020

Thus, it enables individualization of medical cannabis regimens that can be evaluated pharmacokinetically and pharmacodynamically by accepted pharmaceutical models.” Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 266

Clinical Trials Chronic Pain Cannabinoids Patients 266

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

AUGUST 22, 2021

“Looking at the industry as it is growing, we are seeing the emergence of a brand-new sector: the psycheceutical industry, which merges the best of psychedelics and the best of pharmaceuticals. . is using cutting-edge delivery technologies to develop safe and effective psychedelic pharmaceutical medicines. Psycheceutical, Inc.

Pharmaceutical 98

Pharmaceutical Medicine Research and Development Therapy 98

CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. Legal access does not necessarily equate to financial access. Although there is growing access to cannabis medicines, there is an increasing need for credible research and educational platforms.

Access 89

Access Patients Pharmaceutical Education 89

Veriheal

JULY 21, 2022

On July 1, the process of procuring pharmaceutical-approved cannabis was simplified for individuals residing across the state, where the first licensed medical marijuana dispensary opened its doors in August 2020. The latest changes to Virginia’s medical cannabis law adds to a growing list of amendments aimed at improving patient access.

Access 105

Access Dispensary Patients Programs 105

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. I include pharmaceutical drugs in that category. In general, I think that botanical medicine is safer than pharmaceutical medicine. They’re less interested in the pharmaceutical versions.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Americans for Safe Access

OCTOBER 17, 2017

On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA).

Policy 184

Policy DEA Pharmaceutical Legislation 184

Cannabis Law Report

JULY 5, 2021

Access Control. Since the ERP is equipped with all of the company’s information, the access to data is controlled. and each user can only access part of the information. The QA department usually defines the user access to be controlled and each user will have his. Some users can have unique privileges to.

Pharmaceutical 111

Pharmaceutical Data Access Business 111

Veriheal

SEPTEMBER 16, 2020

Epidiolex is the sole cannabis-derived pharmaceutical that has been approved by the FDA – although it is worth noting that the organization has also approved three synthetic cannabis-related products. The post FDA Expands Epidiolex Access for Those with Tuberous Sclerosis Complex appeared first on Cannabis Central.

Access 98

Access Epilepsy Treatment Conditions 98

Cannabis Law Report

JUNE 23, 2021

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations (PRNewsfoto/Valcon Medical A/S).

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. In Virginia, these families were simply asking to be able to possess the medicines they were able to access in other states. This interview has been edited for clarity and space. We need to do more.

Marijuana 231

Marijuana Legalization Programs Oil 231

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? VA resident? West Virginia.

Legislation 250

Legislation Patients Decriminalization Access 250

Americans for Safe Access

FEBRUARY 1, 2019

For, example compound pharmaceutical preparations containing THC would be placed in Schedule III and CBD preparations would be removed from scheduling entirely. The WHO has determined that cannabis and cannabis resin should be removed from Schedule IV of the Single Convention on Narcotic Drugs (which is different than the U.S.

Pharmaceutical 189

Pharmaceutical THC Cannabis CBD 189

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients.

Policy 176

Policy Patients Education Legislation 176

The Fresh Toast

AUGUST 19, 2019

With the stigma of cannabis fading by the day, more families are exploring treatments that are more accessible and less pharmaceutical. Continue reading The Potential Of CBD And Cannabis Within The Anxiety And Autism Community at The Fresh Toast.

CBD 111

CBD Pharmaceutical Treatment Access 111

Cannabis Law Report

JANUARY 23, 2023

VF1883 Pharmaceuticals, a medical cannabis producer based in Benavente, has been declared insolvent by the Santarém Court. According to exclusive information that Cannareporter had access to, […] According to exclusive information that Cannareporter had access to, […]

Pharmaceutical 52

Pharmaceutical Access Cannabis Compliance 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

The Fresh Toast

DECEMBER 21, 2021

As cannabis becomes less stigmatized, the autism community is exploring treatments that are more accessible and less pharmaceutical. THC More Effective Than CBD In Treating Autism, New Preliminary Study Shows. The post THC More Effective Than CBD In Treating Autism, New Preliminary Study Shows appeared first on The Fresh Toast.

THC 105

THC CBD Pharmaceutical Treatment 105

Project CBD

JULY 28, 2023

You need access to sophisticated analytical methods to discern product purity from the isomeric byproducts formed, which is why production from hemp-derived cannabinoid products needs to be done under the appropriate FDA regulations for API [active pharmaceutical ingredient] synthesis and manufacturing.

THC 217

THC Cannabinoids Hemp Research and Development 217

Veriheal

JUNE 22, 2021

Sue Sisley was quoted telling media, “there are thousands of different cannabis varieties that all have unique chemical profiles and produce unique clinical effects, but we didn’t have access to that normal diversity.” Another company that will be cultivating cannabis for research is a pharmaceutical research company.

DEA 66

DEA Access Therapy Cannabinoids 66

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. The live webcast can be accessed here and on the investor page of Marinus’ website. About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc. RADNOR, Pa.–(BUSINESS 484-253-6792.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

MGC Pharma

FEBRUARY 22, 2018

Unfortunately, the regulatory process is fraught with bottlenecks, with no more than 500 Australians having legal access to Medical Cannabis. namely Australia’s aging population. An increasing number of older people are seeking the treatment for conditions such as inflammatory arthritis, autoimmune disease and chronic pain.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. Legislation is pending, House Bill 350, to expand medical cannabis access. Legislation is pending, House Bill 335, to expand access to medical cannabis in New Hampshire. Click here to email your lawmakers in support of medical access.

Legislation 213

Legislation Decriminalization Hemp Patients 213

MGC Pharma

FEBRUARY 21, 2018

Armed with a well-developed agricultural sector, high environmental standards, world class pharmaceutical manufacturing standards, a like-minded government, and grassroot support for the industry, there can be no doubt that Australia is poised to become a Medical Cannabis powerhouse. It’s a climactic time for the Medical Cannabis industry.

Research and Development 100

Research and Development Pharmaceutical Medicine Patients 100

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 2, 2022

The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. By expanding access and, thus use, legalization could permit cannabis to compete with conventional pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Legalization Marijuana Data 52

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients were granted access to low-THC marijuana oil. Andrew Turnage, the executive director of the Georgia Access to Medical Cannabis Commission, spoke on this fact.

Oil 98

Oil Patients Access THC 98

NORML

FEBRUARY 8, 2019

Click here to email your lawmakers in support of medical cannabis access in school. Legislation is pending, House Bill 673 / Senate Bill 1430, to expand medical cannabis access. Click here to email your lawmakers in support of medical access. Click here to email your lawmakers in support of medical cannabis access.

Legislation 187

Legislation Decriminalization Patients Access 187

NORML

FEBRUARY 1, 2019

Click here to email your lawmakers in support of banking access. Legislation is pending, House Bill 5442, to expand patients’ access to medical cannabis in Connecticut. Legislation is pending, SF 77, to expand access to certain medical cannabis products in Iowa. CA resident? CT resident? HI resident? IA resident?

Legislation 177

Legislation Decriminalization Access Patients 177

Cannabis Life Network

MARCH 30, 2023

Decriminalizing small amounts of opioids, cocaine, meth, and ecstasy is designed to “help reduce the barriers and stigma that prevent people from accessing life-saving supports and services.” Now they’re ready to profit from “safe supply.” ” And B.C.’s ’s […] The post What is Stigma?

Decriminalization 92

Decriminalization Pharmaceutical Access Marijuana 92

Cannabis Law Report

SEPTEMBER 8, 2021

TruTrace Technologies is the developer of fully-integrated software, secured on a blockchain infrastructure, that gives clients’ the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory.

Supply Chain 73

Supply Chain Pharmaceutical Seed-To-Sale Events 73

Cannabis Law Report

JUNE 1, 2022

This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

The Blunt Truth

AUGUST 19, 2021

But, in the agency’s view, that approval as an active ingredient in a pharmaceutical means it cannot approve it as a dietary supplement. Do you use an iPhone to access Weedmaps? The industry now looks to Congress to legislate a solution. cannabis in california prisons. Legal sales must start within 180 days. and finally.

Pharmaceutical 111

Pharmaceutical CBD Food Retail 111

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98